Biomaterial Database

Comparison of 3 chelating agents in treatment of experimental manganese poisoning. 1959

J F FRIED, and A LINDENBAUM, and J SCHUBERT

UI	MeSH Term	Description	Entries
D008345	Manganese	A trace element with atomic symbol Mn, atomic number 25, and atomic weight 54.94. It is concentrated in cell mitochondria, mostly in the pituitary gland, liver, pancreas, kidney, and bone, influences the synthesis of mucopolysaccharides, stimulates hepatic synthesis of cholesterol and fatty acids, and is a cofactor in many enzymes, including arginase and alkaline phosphatase in the liver. (From AMA Drug Evaluations Annual 1992, p2035)
D002614	Chelating Agents	Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS.	Chelating Agent,Chelator,Complexons,Metal Antagonists,Chelators,Metal Chelating Agents,Agent, Chelating,Agents, Chelating,Agents, Metal Chelating,Antagonists, Metal,Chelating Agents, Metal
D020149	Manganese Poisoning	Manganese poisoning is associated with chronic inhalation of manganese particles by individuals who work with manganese ore. Clinical features include CONFUSION; HALLUCINATIONS; and an extrapyramidal syndrome (PARKINSON DISEASE, SECONDARY) that includes rigidity; DYSTONIA; retropulsion; and TREMOR. (Adams, Principles of Neurology, 6th ed, p1213)	Nervous System Diseases, Manganese-Induced,Nervous System Poisoning, Manganese,Neurotoxicity Syndrome, Manganese,Poisoning, Manganese,Manganese Neurotoxicity Syndrome,Manganese Neurotoxicity Syndromes,Nervous System Diseases, Manganese Induced,Neurotoxicity Syndromes, Manganese,Syndrome, Manganese Neurotoxicity,Syndromes, Manganese Neurotoxicity